Skip to main content
. 2017 Sep 15;8(60):101175–101188. doi: 10.18632/oncotarget.20933

Figure 9. Model explaining the mechanism for the anti-inflammatory effects of casticin (CAS) in IL-1β–induced A549 cells.

Figure 9